Remedy Plan Therapeutics, a privately-held clinical-stage pharmaceutical company transforming the field of NAMPT inhibition, announced today the initiation of an adult healthy volunteer Phase 1 ...
Hyperbolic, a startup focused on decentralized AI computing and inference services, announced on Tuesday it raised $12 million in a Series A funding round led by Variant and Polychain Capital. The ...